Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Retained Earnings (2022 - 2026)

HeartSciences' Retained Earnings history spans 5 years, with the latest figure at -$82.5 million for Q1 2026.

  • For Q1 2026, Retained Earnings fell 11.44% year-over-year to -$82.5 million; the TTM value through Jan 2026 reached -$82.5 million, down 11.44%, while the annual FY2025 figure was -$76.1 million, 13.01% down from the prior year.
  • Retained Earnings reached -$82.5 million in Q1 2026 per HSCS's latest filing, down from -$80.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$54.4 million in Q2 2022 to a low of -$82.5 million in Q1 2026.
  • Average Retained Earnings over 5 years is -$67.4 million, with a median of -$66.4 million recorded in 2024.
  • Peak YoY movement for Retained Earnings: decreased 10.51% in 2023, then fell 13.03% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$57.8 million in 2022, then decreased by 10.51% to -$63.9 million in 2023, then fell by 11.94% to -$71.5 million in 2024, then fell by 12.63% to -$80.5 million in 2025, then fell by 2.44% to -$82.5 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Retained Earnings are -$82.5 million (Q1 2026), -$80.5 million (Q4 2025), and -$78.2 million (Q3 2025).